Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey D Kent

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Postgraduate Medicine|June 17, 2015
Bioequivalence of diclofenac sodium 2% and 1.5% topical solutions relative to oral diclofenac sodium in healthy volunteersRobert J Holt, Tolu Taiwo, Jeffrey D Kent
Current Medical Research and Opinion|October 28, 2015
Efficacy and safety of diclofenac sodium 2% topical solution for osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled, 4 week studyL Tyler Wadsworth, Jeffrey D Kent, Robert J Holt
The Physician and Sportsmedicine|July 14, 2015
Gastroprotective efficacy and safety of single-tablet ibuprofen/famotidine vs ibuprofen in older personsAlfonso E Bello, Jeffrey D Kent, Robert J Holt
Journal of Clinical Pharmacology|May 20, 2003
The COX-2 selective inhibitor, valdecoxib, does not impair platelet function in the elderly: results of a randomized controlled trialPhilip T Leese, David P Recker, Jeffrey D Kent
The American Journal of Emergency Medicine|July 5, 2002
Valdecoxib does not impair platelet functionPhilip T Leese, Sheela Talwalker, Jeffrey D Kent, et al.
Current Medical Research and Opinion|December 18, 2014
One-year safety of ibuprofen/famotidine fixed combination versus ibuprofen alone: pooled analyses of two 24-week randomized, double-blind trials and a follow-on extensionAlfonso E Bello, Amy Y Grahn, Julie Ball, et al.
Current Medical Research and Opinion|December 16, 2014
One-year open-label safety evaluation of the fixed combination of ibuprofen and famotidine with a prospective analysis of dyspepsiaAlfonso E Bello, Jeffrey D Kent, Amy Y Grahn, et al.
Postgraduate Medicine|August 21, 2014
Risk of upper gastrointestinal ulcers in patients with osteoarthritis receiving single-tablet ibuprofen/famotidine versus ibuprofen alone: pooled efficacy and safety analyses of two randomized, double-blind, comparison trialsAlfonso E Bello, Jeffrey D Kent, Amy Y Grahn, et al.
The Physician and Sportsmedicine|August 4, 2015
Onset and durability of pain relief in knee osteoarthritis: pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxibRobert J Holt, John G Fort, Amy Y Grahn, et al.
The Physician and Sportsmedicine|August 28, 2015
Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxibRobert J Holt, John G Fort, Amy Y Grahn, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Postgraduate Medicine|June 17, 2015
Bioequivalence of diclofenac sodium 2% and 1.5% topical solutions relative to oral diclofenac sodium in healthy volunteersRobert J Holt, Tolu Taiwo, Jeffrey D Kent
Current Medical Research and Opinion|October 28, 2015
Efficacy and safety of diclofenac sodium 2% topical solution for osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled, 4 week studyL Tyler Wadsworth, Jeffrey D Kent, Robert J Holt
The Physician and Sportsmedicine|July 14, 2015
Gastroprotective efficacy and safety of single-tablet ibuprofen/famotidine vs ibuprofen in older personsAlfonso E Bello, Jeffrey D Kent, Robert J Holt
Journal of Clinical Pharmacology|May 20, 2003
The COX-2 selective inhibitor, valdecoxib, does not impair platelet function in the elderly: results of a randomized controlled trialPhilip T Leese, David P Recker, Jeffrey D Kent
The American Journal of Emergency Medicine|July 5, 2002
Valdecoxib does not impair platelet functionPhilip T Leese, Sheela Talwalker, Jeffrey D Kent, et al.
Current Medical Research and Opinion|December 18, 2014
One-year safety of ibuprofen/famotidine fixed combination versus ibuprofen alone: pooled analyses of two 24-week randomized, double-blind trials and a follow-on extensionAlfonso E Bello, Amy Y Grahn, Julie Ball, et al.
Current Medical Research and Opinion|December 16, 2014
One-year open-label safety evaluation of the fixed combination of ibuprofen and famotidine with a prospective analysis of dyspepsiaAlfonso E Bello, Jeffrey D Kent, Amy Y Grahn, et al.
Postgraduate Medicine|August 21, 2014
Risk of upper gastrointestinal ulcers in patients with osteoarthritis receiving single-tablet ibuprofen/famotidine versus ibuprofen alone: pooled efficacy and safety analyses of two randomized, double-blind, comparison trialsAlfonso E Bello, Jeffrey D Kent, Amy Y Grahn, et al.
The Physician and Sportsmedicine|August 4, 2015
Onset and durability of pain relief in knee osteoarthritis: pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxibRobert J Holt, John G Fort, Amy Y Grahn, et al.
The Physician and Sportsmedicine|August 28, 2015
Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxibRobert J Holt, John G Fort, Amy Y Grahn, et al.
Pageof 3